Developer docs
API playgroundTry for free, no card

Search company profiles

Fidmi Medical

Full company profile

uuid00047k8

Namestring
Fidmi Medical
Legal namestring
Fidmi Medical Ltd.
Company typeenum
Private
Founded yearint
2014
Descriptiontext

Fidmi Medical is an Israeli medical device company founded in 2014 and headquartered in the Caesarea Business Park, Israel. The company develops a low-profile percutaneous endoscopic gastrostomy (PEG) enteral feeding device intended to provide long-term gastric access for patients who cannot maintain oral intake, with a design aimed at reducing complications, improving patient comfort, and simplifying replacement compared to conventional PEG tubes. The device holds ISO 13485 certification and received FDA 510(k) clearance in October 2019, positioning it for sale into the global PEG/enteral feeding market — estimated at roughly $800 million with approximately 2.6 million procedures performed annually worldwide.

The company operates as a portfolio company of Trendlines Group, an Israel-based medical and agritech incubator. Through 2021, Fidmi disclosed approximately $4.25 million in total funding across multiple rounds, including a $2 million investment from B. Braun in 2017 and a $2.2 million round in 2021 led by Micro-Tech with participation from Trendlines and Agriline. Fidmi entered the US market in October 2021 under an exclusive distribution agreement with Micro-Tech that also covers China. With 1-10 employees, the company runs a lean operating model, outsourcing commercialization to distribution partners rather than building its own sales force. Its go-to-market relies on Micro-Tech's existing gastroenterology channels in the US and China, with no alternative distribution partners or direct end-customer relationships disclosed.

Short descriptiontext

Fidmi Medical is an Israeli medical device company developing a low-profile PEG enteral feeding device for patients requiring long-term gastrostomy nutrition, commercialized in the US and China through an exclusive distribution agreement with Micro-Tech.

Operating statusenum
Operating
Ownership categoryenum
Headcount rangeband
1–10
akta.pro rankint
HeadquartersMisgav, Israel
HQ citystring
Misgav
HQ countrystring
Israel
HQ regionstring
Middle East
Markets served

Serves global market

Offices1 record

Each record includes

City, Country, Type, Description, Source

Keyword5 values
enteral feeding devices, percutaneous endoscopic gastrostomy, PEG medical devices, gastrostomy tubes, low-profile feeding device
Industry1 code
1Endoscopic Therapeutic & Access Devices (Trocars, dilators, biopsy/ablation tools)
CodeHLAHADANPrimaryYes
NAICS code2 codes
  • Medical Equipment and Supplies Manufacturing3391
  • Surgical Appliance and Supplies Manufacturing339113
SIC code2 codes
  • Surgical & Medical Instruments & Apparatus3841
  • Orthopedic, Prosthetic & Surgical Appliances & Supplies3842
Product category
Enteral Feeding Medical Devices
Social media profiles1 record
GTM motion1 record

Each record includes

Type, Description, Source

Revenue model1 record
1Low-profile PEG Device Sales
TypeHardware Sales
Description

Sale of FDA-cleared low-profile percutaneous endoscopic gastrostomy devices for enteral feeding. The company sells its device through exclusive distribution partnerships with Micro-Tech in the U.S. and China markets.

prnewswire.com
Marketing channels3 records

Each record includes

Title, Type, Stage, Description, Source

Distribution channels2 records

Each record includes

Title, Type, Scope, Target buyer, Description, Source

Cost components5 values
Operations, Technology or R&D, Supply Chain, Marketing or Sales, Personnel
GTM typeB2B
B2B
Offering typeHardware or Manufacturing
Hardware or Manufacturing
Core offering1 text field

Fidmi Medical develops and manufactures a low-profile Percutaneous Endoscopic Gastrostomy (PEG) device for long-term enteral feeding. The device features a flexible rigid-core internal bumper that prevents dislodgement and disassembles for trauma-free removal, a disposable replaceable inner feeding tube that reduces clogging, and an external flexible retention bumper that protects the stoma. The company sells its FDA-cleared medical device through exclusive distribution partnerships with Micro-Tech in the U.S. and China markets.

Differentiator
Functional benefit
Problem solved
Quantifiable outcome1 value
  • Current tubes are changed often due to clogging (up to 45%), degradation, or dislodgement (up to 13%); tube replacement via traction may result in 7.6% gastrointestinal tract perforation leading to peritonitis
Product overview1 text field

Fidmi Medical offers a single core product: its novel low-profile PEG (percutaneous endoscopic gastrostomy) device for enteral feeding. The product integrates three key components—a rigid-core internal bumper, a disposable feeding tube, and an external retention bumper—providing a comprehensive solution for placement, replacement, and removal of enteral feeding devices. This is a unified product designed to overcome drawbacks of existing solutions including frequent clogging, dislodgement, and the need for repeated hospital visits during tube replacement.

Product and service1 record
1Low-Profile PEG Device
CategoryEnteral Feeding Medical Devices
Description

One-step low-profile percutaneous endoscopic gastrostomy (PEG) device for initial placement in patients requiring long-term enteral feeding. Features a flexible rigid-core internal bumper that prevents dislodgment and breaks apart for trauma-free removal, a disposable feeding tube that can be replaced without removing the PEG device, and an external flexible retention bumper that protects the stoma and self-adjusts for fit. Sold to hospitals and gastroenterology departments through exclusive distribution partnerships.

Scale indicator4 records

Each record includes

Type, Value, Description, Source

Partnership2 partners
Strategic tierStrategicTypeStrategic or Co-development PartnerAnnounced on2019-09-19
Description

CoapTech and Fidmi Medical announced a collaboration on groundbreaking g-tube systems in September 2019. CoapTech is also associated with Trendlines Group.

Strategic tierCoreTypeChannel Partner/ Reseller/ Distributor
Description

Micro-Tech Endoscopy USA is Fidmi Medical's exclusive U.S. distributor. Located at 2855 Boardwalk Drive, Ann Arbor, MI 48104. They handle product distribution and customer inquiries for the U.S. market.

Recent move5 records

Each record includes

Date, Type, Title, Description, Source

Expansion highlight4 records

Each record includes

Type, Description

Peers8 records
TypeBroad incumbent
Description

B. Braun is one of the world's largest medical device companies with a broad enteral nutrition and infusion therapy portfolio, and is also an investor in Fidmi. Comparable as both a strategic investor and a potential competitor in the enteral feeding device market.

TypeBroad incumbent
Description

Medtronic (formerly Covidien) operates the Kendall/Dover enteral feeding product line including PEG tubes and feeding accessories. Comparable as a broad incumbent with established gastroenterology distribution channels competing for the same hospital contracts.

TypeBroad incumbent
Description

Boston Scientific is a major global medical device company with a substantial endoscopy and GI portfolio that overlaps with PEG placement and enteral feeding accessories. Comparable as a broad incumbent in the GI/endoscopy space that Fidmi competes against for hospital contracts.

TypeBroad incumbent
Description

BD (formerly Bard) is a global medical technology company that acquired C.R. Bard's PEG/gastrostomy device franchise. Comparable as a broad incumbent in the percutaneous endoscopic gastrostomy device category, with established hospital relationships and significant sales reach.

TypeBroad incumbent
Description

Avanos Medical (formerly Kimberly-Clark Health Care) is a major enteral feeding player with the CORFLO and MIC-KEY feeding tube lines, offering a broad portfolio across enteral nutrition, pain management, and respiratory health. Comparable as an incumbent in the same PEG/gastrostomy category serving hospitals and home-care patients.

TypeDirect peer
Description

Vygon is a medical device company specializing in single-use enteral, vascular, and neonatal products, including PEG tubes and gastrostomy devices. Directly comparable as a focused enteral feeding device supplier serving hospitals and home-care patients globally.

TypeDirect peer
Description

AMT is the most direct competitor to Fidmi — a medical device company that specializes in low-profile gastrostomy (G-tube) and enteral feeding devices, including the popular MINILOG and MIC-KEY button lines. Both companies target the same gastroenterology/PEG customer base with low-profile replacement feeding devices.

TypeBroad incumbent
Description

Cook Medical is a large, diversified private medical device company with a significant endoscopy product line including PEG kits and accessories. Comparable as an incumbent supplier of percutaneous endoscopic gastrostomy devices to gastroenterology departments worldwide.

Market position
Strengths5 records

Each record includes

Headline, Details, Source

Weaknesses5 records

Each record includes

Headline, Details, Source

Competitive moat4 records

Each record includes

Type, Details

Key risks6 records

Each record includes

Headline, Details, Source

Key highlights7 records

Each record includes

Headline, Details, Source

Customer concentration

Classification, Details

Segment2 records

Each record includes

Title, Type, Primary, Description, Pain point addressed, Use case, Source

Ideal customer profile1 record

Each record includes

Profile, Firmographic size, Sales motion, Sales cycle length, Buying structure, Purchase trigger, Buyer persona, Geography, Industry vertical, Primary use case, Description, Pain points, Evidence proof points, Target buyer

Technology focused
No
API detail
Has APIbool
No

Docs URL, Description

AI maturity
App detail

Has app

Feature3 records

Each record includes

Title, Differentiator, Description, Source

Core technology
Revenue estimate
Valuation estimate
Number of profiles
Profiles5 records

Each record includes

Name, Designation, Designation category, Overview, Profile commentary, Source

No data
Compliance3 records

Each record includes

Name, Class, Description

Funding overview

Funding stage, Last funding date, Total funding USD

Funding rounds3 records

Each record includes

Round, Amount USD, Date, Pre money valuation, Total investors, Investors, News

Investors5 records

Each record includes

Name, Type, Date of entry, Rounds participated, Website

Funding detail is available on the Subscription and Enterprise plan.Contact sales →

M&A

Each record includes

Name, Acquisition type, Announced date, Completed date, Status, Website, News

Investment

Each record includes

Name, Round, Announced date, Lead investor, Website, News

M&A and investment is available on the Subscription and Enterprise plan.Contact sales →

Fidmi Medical

Enteral Feeding Medical Devicesfidmimedical.com

Fidmi Medical is an Israeli medical device company developing a low-profile PEG enteral feeding device for patients requiring long-term gastrostomy nutrition, commercialized in the US and China through an exclusive distribution agreement with Micro-Tech.

What Fidmi Medical does

Fidmi Medical is an Israeli medical device company founded in 2014 and headquartered in the Caesarea Business Park, Israel. The company develops a low-profile percutaneous endoscopic gastrostomy (PEG) enteral feeding device intended to provide long-term gastric access for patients who cannot maintain oral intake, with a design aimed at reducing complications, improving patient comfort, and simplifying replacement compared to conventional PEG tubes. The device holds ISO 13485 certification and received FDA 510(k) clearance in October 2019, positioning it for sale into the global PEG/enteral feeding market — estimated at roughly $800 million with approximately 2.6 million procedures performed annually worldwide.

The company operates as a portfolio company of Trendlines Group, an Israel-based medical and agritech incubator. Through 2021, Fidmi disclosed approximately $4.25 million in total funding across multiple rounds, including a $2 million investment from B. Braun in 2017 and a $2.2 million round in 2021 led by Micro-Tech with participation from Trendlines and Agriline. Fidmi entered the US market in October 2021 under an exclusive distribution agreement with Micro-Tech that also covers China. With 1-10 employees, the company runs a lean operating model, outsourcing commercialization to distribution partners rather than building its own sales force. Its go-to-market relies on Micro-Tech's existing gastroenterology channels in the US and China, with no alternative distribution partners or direct end-customer relationships disclosed.

Fidmi Medical firmographics

Firmographics
Name
Fidmi Medical
Legal name
Fidmi Medical Ltd.
Website
https://fidmimedical.com
Company type
Private
Founded year
2014
Operating status
Operating
Headcount range
1–10 employees
Short description
Fidmi Medical is an Israeli medical device company developing a low-profile PEG enteral feeding device for patients requiring long-term gastrostomy nutrition, commercialized in the US and China through an exclusive distribution agreement with Micro-Tech.
Ownership category
akta.pro rank

Fidmi Medical industry classification

Industry
Product category
Enteral Feeding Medical Devices
NAICS
Medical Equipment and Supplies Manufacturing (3391), Surgical Appliance and Supplies Manufacturing (339113)
SIC
Surgical & Medical Instruments & Apparatus (3841), Orthopedic, Prosthetic & Surgical Appliances & Supplies (3842)
akta.pro primary industry
Endoscopic Therapeutic & Access Devices (Trocars, dilators, biopsy/ablation tools) (HLAHADAN)

Keywords

  • Enteral feeding devices
  • Percutaneous endoscopic gastrostomy
  • PEG medical devices
  • Gastrostomy tubes
  • Low-profile feeding device

Where Fidmi Medical is headquartered

Location

Headquarters

HQ city
Misgav
HQ country
Israel
HQ region
Middle East

Offices1 record

Markets served

Fidmi Medical business model

Business model
GTM type
B2B
Offering type
Hardware or Manufacturing
Cost components
Operations, Technology or R&D, Supply Chain, Marketing or Sales, Personnel

Revenue model

  1. Low-profile PEG Device Sales: Sale of FDA-cleared low-profile percutaneous endoscopic gastrostomy devices for enteral feeding. The company sells its device through exclusive distribution partnerships with Micro-Tech in the U.S. and China markets.

Go-to-market motion1 record

Distribution channels2 records

Marketing channels3 records

Fidmi Medical product offering

Product offering

Core offering

Fidmi Medical develops and manufactures a low-profile Percutaneous Endoscopic Gastrostomy (PEG) device for long-term enteral feeding. The device features a flexible rigid-core internal bumper that prevents dislodgement and disassembles for trauma-free removal, a disposable replaceable inner feeding tube that reduces clogging, and an external flexible retention bumper that protects the stoma. The company sells its FDA-cleared medical device through exclusive distribution partnerships with Micro-Tech in the U.S. and China markets.

Product overview

Fidmi Medical offers a single core product: its novel low-profile PEG (percutaneous endoscopic gastrostomy) device for enteral feeding. The product integrates three key components—a rigid-core internal bumper, a disposable feeding tube, and an external retention bumper—providing a comprehensive solution for placement, replacement, and removal of enteral feeding devices. This is a unified product designed to overcome drawbacks of existing solutions including frequent clogging, dislodgement, and the need for repeated hospital visits during tube replacement.

Differentiator

Problem solved

Functional benefit

Products and services

  • Low-Profile PEG Device One-step low-profile percutaneous endoscopic gastrostomy (PEG) device for initial placement in patients requiring long-term enteral feeding. Features a flexible rigid-core internal bumper that prevents dislodgment and breaks apart for trauma-free removal, a disposable feeding tube that can be replaced without removing the PEG device, and an external flexible retention bumper that protects the stoma and self-adjusts for fit. Sold to hospitals and gastroenterology departments through exclusive distribution partnerships.

Quantifiable outcome

  • Current tubes are changed often due to clogging (up to 45%), degradation, or dislodgement (up to 13%); tube replacement via traction may result in 7.6% gastrointestinal tract perforation leading to peritonitis

Companies that use Fidmi Medical

Customer profile

Segments2 records

Ideal customer profiles1 record

Fidmi Medical technology and API

Technology

Technology focussed No

API detail

Has API
No
API docs
API detail

Core technology

AI maturity

App detail

Feature3 records

Fidmi Medical partnerships and signals

Strategic signal

Partnerships

Two partnerships are on record, tiered strategic and core.

  • CoapTechstrategicStrategic or Co-development Partner · 19 September 2019CoapTech and Fidmi Medical announced a collaboration on groundbreaking g-tube systems in September 2019. CoapTech is also associated with Trendlines Group.
  • Micro-Tech Endoscopy USAcoreChannel Partner/ Reseller/ DistributorMicro-Tech Endoscopy USA is Fidmi Medical's exclusive U.S. distributor. Located at 2855 Boardwalk Drive, Ann Arbor, MI 48104. They handle product distribution and customer inquiries for the U.S. market.

Scale indicators4 records

Recent moves5 records

Expansion highlights4 records

Fidmi Medical competitors and assessment

Company assessment

Broad incumbents

  • B. Braun Melsungen AG: B. Braun is one of the world's largest medical device companies with a broad enteral nutrition and infusion therapy portfolio, and is also an investor in Fidmi. Comparable as both a strategic investor and a potential competitor in the enteral feeding device market.
  • Medtronic: Medtronic (formerly Covidien) operates the Kendall/Dover enteral feeding product line including PEG tubes and feeding accessories. Comparable as a broad incumbent with established gastroenterology distribution channels competing for the same hospital contracts.
  • Boston Scientific: Boston Scientific is a major global medical device company with a substantial endoscopy and GI portfolio that overlaps with PEG placement and enteral feeding accessories. Comparable as a broad incumbent in the GI/endoscopy space that Fidmi competes against for hospital contracts.
  • Becton Dickinson (BD): BD (formerly Bard) is a global medical technology company that acquired C.R. Bard's PEG/gastrostomy device franchise. Comparable as a broad incumbent in the percutaneous endoscopic gastrostomy device category, with established hospital relationships and significant sales reach.
  • Avanos Medical: Avanos Medical (formerly Kimberly-Clark Health Care) is a major enteral feeding player with the CORFLO and MIC-KEY feeding tube lines, offering a broad portfolio across enteral nutrition, pain management, and respiratory health. Comparable as an incumbent in the same PEG/gastrostomy category serving hospitals and home-care patients.
  • Cook Medical: Cook Medical is a large, diversified private medical device company with a significant endoscopy product line including PEG kits and accessories. Comparable as an incumbent supplier of percutaneous endoscopic gastrostomy devices to gastroenterology departments worldwide.

Direct peers

  • Vygon: Vygon is a medical device company specializing in single-use enteral, vascular, and neonatal products, including PEG tubes and gastrostomy devices. Directly comparable as a focused enteral feeding device supplier serving hospitals and home-care patients globally.
  • Applied Medical Technology (AMT): AMT is the most direct competitor to Fidmi — a medical device company that specializes in low-profile gastrostomy (G-tube) and enteral feeding devices, including the popular MINILOG and MIC-KEY button lines. Both companies target the same gastroenterology/PEG customer base with low-profile replacement feeding devices.

Market position

Strengths5 records

Weaknesses5 records

Competitive moat4 records

Key risks6 records

Key highlights7 records

Customer concentration

Fidmi Medical social profiles

Digital presence

Fidmi Medical compliance and trust

Trust signal

Compliance3 records

Fidmi Medical financial estimates

Financial estimate

Revenue estimate

Valuation estimate

Fidmi Medical leadership team

Management profile

Number of profiles

Profiles5 records

Fidmi Medical funding detail

Funding detail

Funding overview

Funding rounds3 records

Investors5 records

Funding detail is available on the Subscription and Enterprise plan.Contact sales →

Fidmi Medical M&A and investment

M&A and investment

M&A

Investments

M&A and investment is available on the Subscription and Enterprise plan.Contact sales →

Frequently asked questions about Fidmi Medical

What does Fidmi Medical do?

Fidmi Medical develops and manufactures a low-profile Percutaneous Endoscopic Gastrostomy (PEG) device for long-term enteral feeding. The device features a flexible rigid-core internal bumper that prevents dislodgement and disassembles for trauma-free removal, a disposable replaceable inner feeding tube that reduces clogging, and an external flexible retention bumper that protects the stoma. The company sells its FDA-cleared medical device through exclusive distribution partnerships with Micro-Tech in the U.S. and China markets.

Is Fidmi Medical a public or private company?

Fidmi Medical is a private company. It is classified as venture growth investor backed and is currently operating.

When was Fidmi Medical founded?

Fidmi Medical was founded in 2014. It employs 1 to 10 people.

Where is Fidmi Medical based?

Fidmi Medical is headquartered in Misgav, Israel, in the Middle East region.

How does Fidmi Medical make money?

One revenue line is on record: low-profile PEG Device Sales.

Who are Fidmi Medical's main competitors?

Broad incumbents on record are B. Braun Melsungen AG, Medtronic, Boston Scientific, Becton Dickinson (BD), Avanos Medical and Cook Medical. Direct peers are Vygon and Applied Medical Technology (AMT).

Does Fidmi Medical have an API?

No public API is recorded for Fidmi Medical.

What industry is Fidmi Medical in?

Fidmi Medical's product category is Enteral Feeding Medical Devices. Its primary akta.pro industry code is HLAHADAN, Endoscopic Therapeutic & Access Devices (Trocars, dilators, biopsy/ablation tools). Its NAICS code is 3391 and its SIC code is 3841.

Unlock the full company data

50 free credits on sign-up, no credit card required.

Contact sales
Live signals
PR NewswireFidmi Medical Launches U.S. Sales of Novel Low-Profile PEG Device and Raises $2.2 MillionFidmi Medical Ltd. announced on October 11, 2021 that it completed a $2.2 million financing round and launched its FDA-cleared low-profile Percutaneous Endoscopic Gastrostomy device in the U.S. Investors include Micro-Tech (Nanjing) Co., Ltd., The Trendlines Group and Agriline. Micro-Tech is named the exclusive distributor in the U.S. and China.PR NewswireFidmi Medical Receives FDA Regulatory Clearance for Low-profile Enteral Feeding DeviceFidmi Medical Ltd., an Israeli medical device company, received 510(k) regulatory clearance from the FDA for its low-profile enteral feeding device designed for patients requiring long-term nutritional support. The device features an easily replaceable inner tube that patients can change without returning to healthcare facilities, addressing common complications like clogging and dislodgement that drive up healthcare costs. This clearance enables Fidmi Medical to enter the US market and follows a recent collaboration announced with CoapTech LLC in September 2019.PR NewswireFidmi Medical Raises US$2 Million from B. Braun Melsungen AGFidmi Medical Ltd., an Israeli portfolio company of The Trendlines Group, announced receiving a US$2 million investment from German medical device company B. Braun Melsungen AG. The funding will be used to complete clinical trials and prepare for market entry of Fidmi's low-profile PEG enteral feeding device, which features a replaceable inner tube to prevent clogging and a soft internal structure to prevent dislodgement. B. Braun's investment affirms confidence in the company's product, which is currently undergoing human trials in a market that sees approximately 1.3 million initial insertions and 3 million replacement procedures annually.